Skip to content

CingolaniLab

Heersink School of Medicine

  • Cingolani Lab @ UAB
  • Research
  • People
  • Publications
  • Structures
  • Contact
  • News
  • Cingolani Lab @ UAB
  • Research
  • People
  • Publications
  • Structures
  • Contact
  • News

Dec 8, 2023. Liam’s paper is finally accepted in Science Advances

Posted on December 11, 2023December 11, 2023Author gcingolaCategories Uncategorized

Congrats, Liam: your 1st-author paper entitled ‘Structural basis for nuclear import of Hepatitis B Virus (HBV) nucleocapsid core’ has been formally accepted in the Science Advances!!

Post navigation

Previous Previous post: Nov 7, 2023. Stephano’s paper is accepted in the Journal of Mol Biology
Next Next post: Jan 8, 2024. Brittney Bird and James Scherer join the lab for their Master’s thesis

Recent News

  • May 2, 2025. Congrats Stephanie Suinn for being awarded a prestigious F31 fellowship!
  • Oct 25, 2024. DEV paper is featured in UAB News!
  • Oct 8, 2024. Our first collaborative paper with Armata Pharmaceuticals is out in Communications Biology!
  • Oct 1, 2024. DEV paper is out in Nature Communications!
  • June 8, 2024. Welcome to the new Center for Integrative Structural Biology

Bookmarks

  • Parent Administrative Unit
  • UAB Home
Theme: Maisha Lite
UAB the University of Alabama at Birmingham home
  • Login
  • |
  • Privacy
  • |
  • Terms of Use
  • |
  • © 2025 The University of Alabama at Birmingham
UAB is an Equal Employment/Equal Educational Opportunity Institution dedicated to providing equal opportunities and equal access to all individuals regardless of race, color, religion, ethnic or national origin, sex (including pregnancy), genetic information, age, disability, religion, and veteran’s status. As required by Title IX, UAB prohibits sex discrimination in any education program or activity that it operates. Individuals may report concerns or questions to UAB’s Assistant Vice President and Senior Title IX Coordinator. The Title IX notice of nondiscrimination is located at uab.edu/titleix.